Skip to content
healthcare.dev

Omidria

NDC 62225-600, phenylephrine and ketorolac, injection, solution, concentrate, from Omeros Corporation.

Product NDC
62225-600
Status
Listed
Labeler
Omeros Corporation
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAOCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205388
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62225-600 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENYLEPHRINE10.16 mg/mL
  • KETOROLAC2.88 mg/mL

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitor [EPC]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/21470688-4e81-4ea5-ac38-f72e10552e7e

Use it

Look up 62225-600 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62225-600 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62225-600. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.